NewLink Genetics Corp (NASDAQ:NLNK)

4.49
Delayed Data
As of 4:00pm ET
 -0.02 / -0.44%
Today’s Change
3.75
Today|||52-Week Range
20.47
-44.64%
Year-to-Date

Today’s Trading

Previous close4.51
Today’s open4.48
Day’s range4.36 - 4.58
Volume794,847
Average volume (3 months)1,053,908
Market cap$291.7M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+21.77%
Earnings growth (this year)-2.32%
Earnings growth (next 5 years)+14.35%
Revenue growth (last year)-19.73%
P/E ratioNM
Price/Sales8.84
Price/Book1.92

Competitors

 Today’s
change
Today’s
% change
FBIOFortress Biotech Inc-0.10-2.33%
SBBPStrongbridge Biophar...+0.05+0.66%
NEOSNeos Therapeutics In...0.000.00%
DRRXDURECT Corp-0.03-1.40%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$28.7M
Annual profit (last year)-$72.0M
Net profit margin-250.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Director
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts